Yuichi Hikichi
Yamaha (Japan)(JP)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Vascular Tumors and Angiosarcomas, Chronic Lymphocytic Leukemia Research, 3D Printing in Biomedical Research
Most-Cited Works
- → TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens(2011)77 cited
- → Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis(2006)57 cited
- → Discovery of TAK-960: An orally available small molecule inhibitor of polo-like kinase 1 (PLK1)(2013)48 cited
- → Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors(2016)18 cited
- → All-trans retinoic acid-induced ADAM28 degrades proteoglycans in human chondrocytes(2009)14 cited
- → Abstract 3951: EphA10 exhibits anti-apoptotic activity through its dominant-negative role for EphA signaling in cancer cells(2010)4 cited
- → Abstract 4247: Miniaturizing patient-derived organoid screening assays for predictive drug testing(2024)1 cited
- → Abstract A207: Discovery of molecular mechanisms underlying cellular sensitivity to the PLK1 inhibitor TAK-960.(2011)1 cited
- → Data from TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens(2023)
- → Abstract 4109: Discovery of a novel cancer-specific antigen for therapeutic targeting using the Oncotope platform(2024)